彭布拉医疗

最新新闻

• 公司公告
  Sailor Pen: Notice Regarding Financial Information of Non-Listed Parent Companies, etc.
  JPX · 2026/3/31
• 评级变动
  Citi Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
  \u5e02\u573a\u8d44\u8baf · 2026/4/7
• 评级变动
  Citi Maintains Penumbra(PEN.US) With Hold Rating, Cuts Target Price to $350
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• CCORF Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• RBC Capital Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 公司公告
  Eisai: The subcutaneous formulation of the early-stage Alzheimer's disease treatment "Rekembi," the "Rekembi Subcutaneous Injection 250 mg Pen," has received approval in Japan.
  JPX · 2026/9/16
• Citi Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $350
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Needham Maintains Penumbra(PEN.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  RBC Capital Initiates Penumbra(PEN.US) With Hold Rating, Announces Target Price $374
  \u5e02\u573a\u8d44\u8baf · 2026/8/1
• Le Pen, who has consistently advocated for dialogue with Russia, issued a rare condemnation this time.
  Guancha Syndicate · 2026/9/20
• 公司公告
  Hualan Co., Ltd.: Announcement on the joint review and approval results of the company\'s aluminum caps and formulations for pen syringes changed to “A” status
  SZSI · 2025/11/6
• 评级变动
  Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $320
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• Le Pen pushes for €140 billion in spending cuts and a constitutional referendum; Citadel executive warns that France has no room for error.
  wallstreetcn · 2026/10/7
• 评级变动
  BTIG Maintains Penumbra(PEN.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/1/27
• 公司公告
  Sailor Pen: Matters concerning controlling shareholders, etc.
  JPX · 2026/3/31
• 评级变动
  Wells Fargo Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  Evercore Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $360
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 公司公告
  Penumbra: Penumbra, Inc. (Election Merger) - Anticipated Adjustment Option Symbol: PEN New Symbol: BSX1
  OCC · 2026/4/18
• 评级变动
  Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $335
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $345
  \u5e02\u573a\u8d44\u8baf · 2026/4/6
• 评级变动
  Citi Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $350
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• RBC Capital Maintains Penumbra(PEN.US) With Hold Rating, Maintains Target Price $374
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  UBS Downgrades Penumbra(PEN.US) to Hold Rating, Raises Target Price to $374
  \u5e02\u573a\u8d44\u8baf · 2026/1/20

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。